LFGTX | Focused Growth Fund Class R5 | Lord Abbett

Tracked Funds

You have 0 funds on your mutual fund watch list.

Begin by selecting funds to create a personalized watch list.

(as of 12/05/2015)

Pending Orders

You have 0 items in your cart.

Subscribe and order forms, fact sheets, presentations, and other documents that can help advisers grow their business.

 

Focused Growth Fund

Track this Fund
Add to Hypo Tool

Summary

Summary

What is the Focused Growth Fund?

The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of U.S. companies.

Fund Basicsas of 10/31/2022

Total Net Assets
$33.73 M
Inception Date
02/01/2019
Dividend Frequency
Monthly (Daily Accrual)
Fund Gross Expense Ratio
1.24%
Fund Net Expense Ratio
0.80%
Number of Holdings
33

TEN LARGEST HOLDINGS as of 10/31/2022View Portfolio

Holding Assets
Apple Inc 9.5%
Microsoft Corp 7.0%
Alphabet Inc 4.1%
Mastercard Inc 3.9%
Eli Lilly & Co 3.8%
Vertex Pharmaceuticals Inc 3.7%
Amazon.com Inc 3.5%
UnitedHealth Group Inc 3.4%
Cheniere Energy Inc 3.2%
Tesla Inc 3.1%

INVESTMENT TEAM

F. Thomas O'Halloran
F. Thomas O'Halloran, CFA, J.D.

Partner & Portfolio Manager

35 Years of Industry Experience

Vernon Bice
Vernon Bice, CMT

Portfolio Manager

21 Years of Industry Experience

Matthew R. DeCicco
Matthew R. DeCicco, CFA

Partner & Director of Equities

21 Years of Industry Experience

Supported By 41 Investment Professionals with 19 Years Avg. Industry Experience

Your Representative

To contact your representative, enter your zip code and select your channel below.

Performance

Performance

Fund Expense Ratio :

Gross 1.24%

Net 0.80%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 01/31/2019
w/o sales charge -32.64% -35.99% 13.56% - - 13.97%
Lipper Category Avg. Multi-Cap Growth Funds -27.96% -27.87% 7.01% - - -
Russell 1000® Growth Index -23.26% -21.64% 11.79% - - 14.81%

Fund Expense Ratio :

Gross 1.24%

Net 0.80%

Fund Expense Ratio :

Gross 1.24%

Net 0.80%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 01/31/2019
w/o sales charge -35.46% -31.82% 15.56% - - 13.32%
Lipper Category Avg. Multi-Cap Growth Funds -34.49% -31.72% 6.19% - - -
Russell 1000® Growth Index -30.66% -22.59% 10.67% - - 12.38%

Fund Expense Ratio :

Gross 1.24%

Net 0.80%

Year Fund Returns Russell 1000® Growth Index
2021 13.20% 27.60%
2020 86.65% 38.49%
2019 15.93% 36.39%
Year Q1 Q2 Q3 Q4 Yearly Returns
2022 -12.97% -24.41% -1.88% - -35.52%
2021 -2.30% 9.72% -0.03% 5.63% 13.20%
2020 -7.13% 42.04% 21.32% 16.63% 86.65%
2019 - 4.49% -8.29% 13.14% 15.93%

NAV HISTORICAL PRICES

Date Net Asset Value

Portfolio

Portfolio

Portfolio Positioningas of 9/30/2022

  • The Fund is designed and managed to provide investors with access to the most innovative, high-growth companies in their respective industries. Our investment research process is iterative and continuous and includes three primary components: 1) identifying innovators and superior businesses, 2) assessing and quantifying operating momentum, and 3) assessing and quantifying stock price momentum
  • The inflationary environment has ushered in quantitative tightening and an increasingly hawkish Federal Reserve (the Fed), which has led to a challenging backdrop for innovation growth stocks. From a technical standpoint, most indicators continue to be weak with both market breadth and market sentiment trading at oversold levels. We continue to monitor supply and demand imbalances, inflationary pressures, and Fed policy. However, we have seen some positive signs over the last few months, such as earnings resiliency, a potential for peaking in food and commodity inflation, and technical strength in secular growth areas, such as biotechnology.
  • Accordingly, we continue to seek a reasonable balance of offensive and defensive stocks. Our offensive positioning consists largely of stocks that have sold off significantly and are now at the lower end of the market capitalization categories, while defensive positioning is mainly focused on areas that have healthy business conditions and constructive technical patterns, such as energy and pharmaceuticals.
  • Looking ahead into 2023 and beyond, our view continues to be that the powerful secular forces that kept inflation low before the pandemic - namely demographics, high debt levels, and the technology revolution - will reassert themselves at some point. Tighter monetary and fiscal policy, too, should cause inflation to decelerate from very high levels. However, until that happens, we are likely to continue to face a hostile Fed.
  • We remain bullish on the long-term outlook for equities because the technology revolution is ever more powerful with each passing year, providing a supportive backdrop for innovation in the Consumer, Communications, Healthcare, and Technology sectors in the decade ahead. The opportunity set of terrific growth companies in these sectors at more reasonable valuations continues to expand. Many of these companies have dominant market positions, are experiencing tremendous growth, are very early on in their penetration, and have years of high compounding annual growth ahead.

PORTFOLIO DETAILS as of 10/31/2022

Total Net Assets
$33.73 M
Number of Holdings
33
Weighted Average Market Cap.
582.8 B
P/B Ratio
11.6x
P/E Ratio
34.9x

Contributors & Detractors as of  09/30/2022

Contributors

Holding Contribution
Enphase Energy, Inc. 0.7%
Tesla Motors, Inc. 0.7%
Arista Networks, Inc. 0.5%
Cheniere Energy Inc 0.5%
NVIDIA Corp. 0.4%

Detractors

Holding Contribution
Microsoft Corp. -0.8%
Alphabet Inc -0.7%
Mongodb Inc -0.5%
Bill Com Hldgs Inc -0.4%
Clear Secure Inc -0.4%

Attribution Analysis 

Focused Growth Fund Benchmark Variance
Sector Avg. Weight Base Return Avg. Weight Base Return Stock Selection Group Weight Total

Fees & Expenses

Fees & Expenses

EXPENSE RATIOas of 11/30/2022

Fund Gross Expense Ratio Fund Net Expense Ratio
1.24% 0.80%

Fund Documents

Fund Documents

Download fund documents & literature, create email subscriptions, and place direct mail order

0Documents selected
Order
n/a
Portfolio Holdings 1Q
Publish Date:11/03/2015
n/a
Portfolio Holdings 3Q
Publish Date:11/03/2015
Summary Prospectus
Publish Date:11/03/2015
n/a
Statutory Prospectus
Publish Date:11/03/2015
SAI
Publish Date:11/03/2015
Annual Report
Publish Date:11/03/2015
Semi-Annual Report
Publish Date:11/03/2015
Fact Sheet
Publish Date:11/03/2015
Commentary
Publish Date:11/03/2015

To order literature visit full website

You may add to your cart by selecting quantities in each row below.

No rows selected. Please Go back and select at least one fund document

 
Quantity
Quantity
Remove
Remove

Select funds to run a Morningstar Hypothetical Report.

    Please confirm your literature shipping address

    Please review the address information below and make any necessary changes.

    All literature orders will be shipped to the address that you enter below. This information can be edited at any time.

    Current Literature Shipping Address

    * Required field